What companies are 2696.HK's competitors?

Shanghai Henlius Biotech, Inc. (2696.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 2696.HK compare to its peers?

The peer comparison table on this page shows Shanghai Henlius Biotech, Inc. (2696.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 2696.HK operate in?

Shanghai Henlius Biotech, Inc. (2696.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

2696.HK

Shanghai Henlius Biotech, Inc.

HKSE·Biotechnology · Healthcare

HK$57.75HK$0.35−0.60%

Market capHK$31.39B·Market closed·Jul 23 2:47 AM UTC

Frequently Asked Questions About 2696.HK

What companies are 2696.HK's competitors?: Shanghai Henlius Biotech, Inc. (2696.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 2696.HK compare to its peers?: The peer comparison table on this page shows Shanghai Henlius Biotech, Inc. (2696.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 2696.HK operate in?: Shanghai Henlius Biotech, Inc. (2696.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

2696.HK

Shanghai Henlius Biotech, Inc.

HKSE·Biotechnology · Healthcare

HK$57.75HK$0.35−0.60%

Market capHK$31.39B·Market closed·Jul 23 2:47 AM UTC

Peers


9995.HK	RemeGen Co., Ltd.	HK$85.95	HK$47.6B
6821.HK	Asymchem Laboratories (Tianjin) Co., Ltd.	HK$118.30	HK$42.7B
1548.HK	Genscript Biotech Corporation	HK$15.94	HK$34.8B
2096.HK	Simcere Pharmaceutical Group Limited	HK$13.05	HK$33.5B
0867.HK	China Medical System Holdings Limited	HK$12.34	HK$30.0B
1513.HK	Livzon Pharmaceutical Group Inc.	HK$25.90	HK$28.3B
1877.HK	Shanghai Junshi Biosciences Co., Ltd.	HK$18.91	HK$26.6B
9606.HK	Duality Biotherapeutics, Inc.	HK$235.40	HK$21.3B
9688.HK	Zai Lab Limited	HK$16.02	HK$18.1B
6855.HK	Ascentage Pharma Group International	HK$36.86	HK$13.7B

Frequently Asked Questions About 2696.HK

What companies are 2696.HK's competitors?: Shanghai Henlius Biotech, Inc. (2696.HK)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 2696.HK compare to its peers?: The peer comparison table on this page shows Shanghai Henlius Biotech, Inc. (2696.HK) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 2696.HK operate in?: Shanghai Henlius Biotech, Inc. (2696.HK) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.